Results

Total Results: 2,015 records

Showing results for "type".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/icd-categories-prevalence-reimbursement_research.pdf
    January 01, 2011 - Number of Beneficiaries, Number of Claims, and Total Medicare Reimbursement in File Type by 5-Digit … , 2006-2009 Number of Beneficiaries, Number of Claims, and Total Medicare Reimbursement in File Type … , 2006-2009 Number of Beneficiaries, Number of Claims, and Total Medicare Reimbursement in File Type … , 2006-2009 Number of Beneficiaries, Number of Claims, and Total Medicare Reimbursement in File Type … , 2006-2009 Number of Beneficiaries, Number of Claims, and Total Medicare Reimbursement in File Type
  2. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_executive.pdf
    November 01, 2009 - The spectrum of included patients varied depending on the cancer type. … Comparators assessed in the randomized controlled trials Cancer type and center Comparison N Survival … Comparators assessed in the nonrandomized comparative studies Cancer type and center Comparison N Survival
  3. effectivehealthcare.ahrq.gov/sites/default/files/presentation.ppt
    August 01, 2009 - One can readily appreciate the number of studies conducted — stratified by cancer type, designs, and … This type of summary could tempt readers to draw a mental summary effect, so its purpose should be stated
  4. Hi Les, (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rtc-design-principles_research.pdf
    January 01, 2009 - If the benefits of an existing test-plus-treatment strategy have already been established, the type … identify what types of comparative evidence are needed to evaluate a new test; (2) describe how the type … • Specify the type of comparative evidence needed to measure these differences. … Multiple flow diagrams may be needed if the role of the new test or the type of comparator differs for … Identifying the Type of Comparative Evidence Needed for Test Evaluation 1.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
    January 01, 2021 - Caucasian: 41% vs. 33% vs. 37% Duration of symptoms: 42 vs. 47 vs. 67 months, p<0.001 Pain etiology/type … 43 vs. 37 vs. 37 years Female: 77% vs. 78% vs. 75% Race: NR Duration of symptoms: NR Pain etiology/type … B Age: 66 vs. 66 years Female: NR Race: NR Duration of symptoms: NR Pain etiology/type or diagnostic … (years): ≤1: 3% vs. 5% < 1 to 5: 50% vs. 32% < 5 to 10: 29% vs. 44% > 10: 19% vs. 20% Pain etiology/type … C Age: NR Female: NR Race: NR Ethnicity: NR Duration of Symptoms: NR Pain etiology/type or diagnostic
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
    January 01, 2021 - Caucasian: 41% vs. 33% vs. 37% Duration of symptoms: 42 vs. 47 vs. 67 months, p<0.001 Pain etiology/type … 43 vs. 37 vs. 37 years Female: 77% vs. 78% vs. 75% Race: NR Duration of symptoms: NR Pain etiology/type … B Age: 66 vs. 66 years Female: NR Race: NR Duration of symptoms: NR Pain etiology/type or diagnostic … (years): ≤1: 3% vs. 5% < 1 to 5: 50% vs. 32% < 5 to 10: 29% vs. 44% > 10: 19% vs. 20% Pain etiology/type … C Age: NR Female: NR Race: NR Ethnicity: NR Duration of Symptoms: NR Pain etiology/type or diagnostic
  7. effectivehealthcare.ahrq.gov/sites/default/files/community-based-participatory-research-slides.pptx
    January 01, 2013 - Please use the chat feature to type and submit your questions. … community benefit program since 2009 Comprehensive diabetes management for adult, medically underserved, Type … and patient input, we added a food security measure and learned that almost 57% of the patients with type … Community Forum Community Forum Please remember to use the chat feature to type and submit your questions
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/quality-gap-palliative-hospice_research-protocol.pdf
    June 27, 2011 -  Comparators For KQ 1, we will abstract the type(s) of QI interventions used in each article … evaluate applicability for included studies, we will extract the relevant patient population (cancer type
  9. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - Type of control group (historic control vs. concurrent control vs. none) 4. … Design Brief Description Control Control Type Followup Temporality Strengths Weaknesses Readings … Design Brief Description Control Control Type Followup Temporality Strengths Weaknesses Readings … Design Brief Description Control Control Type Followup Temporality Strengths Weaknesses Readings … We are not aware of published hedges for this type of exclusion.
  10. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - Type of control group (historic control vs. concurrent control vs. none) 4. … Design Brief Description Control Control Type Followup Temporality Strengths Weaknesses Readings … Design Brief Description Control Control Type Followup Temporality Strengths Weaknesses Readings … Design Brief Description Control Control Type Followup Temporality Strengths Weaknesses Readings … We are not aware of published hedges for this type of exclusion.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
    September 01, 2015 - denote subcategories within a broad priority area (e.g., breast cancer, peripheral artery disease, type … Meeting abstracts reviewed for leads (continued) A-14 Resource Name and Type (1-11; see Key at … Meeting abstracts reviewed for leads (continued) A-15 Resource Name and Type (1-11; see Key at … Meeting abstracts reviewed for leads (continued) A-16 Resource Name and Type (1-11; see Key at … 1, Type 2, Metabolic Syndrome 08 Functional limitations and disability Examples of subcategories:
  12. effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
    September 01, 2015 - denote subcategories within a broad priority area (e.g., breast cancer, peripheral artery disease, type … Meeting abstracts reviewed for leads (continued) A-14 Resource Name and Type (1-11; see Key at … Meeting abstracts reviewed for leads (continued) A-15 Resource Name and Type (1-11; see Key at … Meeting abstracts reviewed for leads (continued) A-16 Resource Name and Type (1-11; see Key at … 1, Type 2, Metabolic Syndrome 08 Functional limitations and disability Examples of subcategories:
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/field-triage-glascow_executive.pdf
    January 01, 2017 - These include variability in patient populations (e.g., type of trauma, demographic characteristics … the tGCS or mGCS, timing, or setting) impacted results, as well as study design characteristics (type … were similar in subgroups stratified by age (child vs. mixed populations of adults and children), type … • Type of trauma: Effects on discrimination between the tGCS versus the mGCS were similar in studies … applicability of the evidence, its applicability to specific patient populations (e.g., specific type
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_clinician.pdf
    August 01, 2015 - potential benefits and the acute and late harms of the proposed RT for the individual patient given the type … patient’s and/or caregiver’s preferences �� The likely out-of-pocket expense to the patient for each type
  15. effectivehealthcare.ahrq.gov/sites/default/files/dyspnea-advanced-cancer-summary-1.pdf
    November 01, 2020 - Interventions for Breathlessness in Patients With Advanced Cancer: Evidence Summary Comparative Effectiveness Review Number 232 Interventions for Breathlessness in Patients With Advanced Cancer Evidence Summary Main Points For patients with advanced cancer: • Airflow interventions (fans) were …
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-agitation-aggression_research-protocol.pdf
    November 13, 2014 - delivered directly to patients with dementia to reduce agitated and aggressive behavior Intervention Type … Source: www.effectivehealthcare.ahrq.gov Published online: November 13, 2014 5 Intervention Type … Criteria for Inclusion Study Enrollment Studies that enroll persons diagnosed with dementia (any type … Publication type Published in peer reviewed journals. Language of Publication English B. … Agitated behavior in persons with dementia: the relationship between type of behavior, its frequency
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
    March 01, 2012 - 1 receptor blockers"[MeSH Terms] OR "angiotensin ii type 1 receptor blockers"[tw] OR "angiotensin … Aliskiren combined with losartan in type 2 diabetes and nephropathy. … Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 … Aliskiren combined with losartan in type 2 diabetes and nephropathy. … Aliskiren combined with losartan in type 2 diabetes and nephropathy.
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-making-sure-evidence-understood.pdf
    July 01, 2020 - Making Sure That Evidence Is Understood and Used Making Sure That Evidence Is Understood and Used: Engaging With the Agency for Healthcare Research and Quality in Evidence Reviews Why Engage With AHRQ? The Agency for Healthcare Research and Quality (AHRQ) wants to engage with organizations to promote the use…
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_technical-brief.pdf
    December 01, 2014 - Distribution of All Abstracts by Study Type ......................................................... … Distribution of All Abstracts by Skin Cancer Type ................................................... … Type of techniques/modalities            b. Postulated advantages and disadvantages? … Distribution of all abstracts by study type RCT = randomized, controlled trial Over half of the … This type can be in either reflectance or fluorescence mode.
  20. WITHIN 3 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/shah.pdf
    May 29, 2025 - We might refer to that as a Web 1.0-type portal where there's a lot of great content. … terminology that we use today, but then it moved into what I would -- I would call the second generation-type … You know, I think physicians are -- are used to being hammered by, you know, all kinds of marketing-type … Where all the others are sort of voluntary-type communities where people come in and you really have

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: